Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TBPH
TBPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TBPH News
Theravance Biopharma Under Investigation for Securities Fraud Claims
3d ago
PRnewswire
Theravance Biopharma Q1 Earnings Analysis
3d ago
seekingalpha
Theravance Biopharma Reports Strong Q1 2026 Financial Results and Strategic Restructuring
3d ago
PRnewswire
THERAVANCE BIOPHARMA INC ANTICIPATES AROUND 60% DECREASE IN OPERATING EXPENSES DUE TO RESTRUCTURING
3d ago
moomoo
Theravance Biopharma Under Investigation for Securities Fraud Claims
May 01 2026
PRnewswire
Summers Value Fund LP Reports -2.7% Return in Q1 2026, Underperforming Indices
Apr 29 2026
seekingalpha
Theravance Biopharma Under Investigation for Securities Fraud Claims
Apr 28 2026
Globenewswire
Theravance Biopharma Under Investigation for Securities Fraud
Apr 21 2026
Globenewswire
Schall Law Firm Investigates Theravance Biopharma for Securities Violations
Apr 08 2026
Globenewswire
Theravance Biopharma Reports Declining R&D Costs Post CYPRESS Enrollment
Apr 01 2026
Newsfilter
THERAVANCE BIOPHARMA INC - RESOLUTION OF ALL PENDING HATCH-WAXMAN LITIGATION CONCERNING YUPELRI - SEC FILING
Mar 30 2026
moomoo
Theravance Biopharma Reports Q4 2025 Financial Results
Mar 19 2026
seekingalpha
Theravance Biopharma Reports Record Q4 2025 Results and Strategic Restructuring
Mar 19 2026
PRnewswire
Theravance Biopharma Restructuring Plan and Financial Performance
Mar 19 2026
Newsfilter
Theravance Biopharma Reaffirms Financial Guidance Amid Trial Failure Risks
Mar 18 2026
PRnewswire
Theravance Biopharma Reaffirms Financial Guidance Amid Trial Failure
Mar 18 2026
Newsfilter
Show More News
